This summer, a team of IDIBAPS researchers travelled Damaturu, Nigeria, to lead the first edition of an intensive cours1
Funded by the European Union, META-BRAIN project presents an innovative approach to controlling brain activity by means of nanotechnology, with reduc1
The document establishes the basis for the exploitation and development of patented technology, owned by six research centers, including IDIBAPS.
The Joan Rodés-Josep Baselga Advanced Research Contracts in Oncology and Neurodegenerative Diseases, awarded by the BBVA Foundation and Hospital Clín1
A study led by researchers from IBEC and IDIBAPS achieves, for the first time, the control of brain state transitions using a molecule responsive to1
Artigas is the head of the IDIBAPS-IIBB-CSIC research group Systems Neuropharmacology, which works to find out the alterations of the neuro1
Researchers of IDIBAPS have participated in an interdisciplinary research study of the UB in which there have been identified two potential candidate1
About 40 % of the affected patients with Huntington’s disease –a neurodegenerative pathology- show depression symptoms, even in early stages before t1
